Why the study?
Many randomized controlled trials have flaws in design, conduct, and reporting, can be futile, or may be fabricated, undermining trustworthiness and clinical evidence quality.
Key points are not available for this paper at this time.
Design
Narrative review
Answers are grounded in this paper and cite their sources.
Flawed RCTs undermine evidence trustworthiness; leaves open reforms needed in trial design before guiding cardiovascular practice.
The randomised controlled trial is the foundation of clinical research; yet there is concern that many trials have flaws in design, conduct, and reporting that undermine trustworthiness. Common flaws in trials include high risk of bias, small size, outcomes irrelevant to clinical care and patient's experience, and inability to detect efficacy even if present. These flaws carry forward into systematic reviews, which can confer the label of 'high-quality evidence' on inadequate data. Trials can be futile because their flaws mean that they cannot deliver any meaningful result in that different results in a small number of patients would be sufficient to change conclusions. Some trials have been discovered to be fabricated, the number of which is growing. The fields of anaesthesia and pain have more fabricated trials than other clinical fields, possibly because of increased vigilance. This narrative review examines these themes in depth whilst acknowledging an inescapable conclusion: that much of our clinical evidence is in trouble, and special measures are needed to bolster quality and confidence.
No takes yet. Share an insight, caveat, or question.
Moore et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: